By mapping the development trajectory of immune precursor cells, A*STAR scientists showed that plasmacytoid dendritic cells were incorrectly classified in the immune ‘family tree.’
Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.
A*STAR scientists have found a way to strengthen the immune response to adenovirus infection using engineered antibodies.
A gene variant more common among East Asians is responsible for milder symptoms and better outcomes during hepatitis B infection.
Researchers at A*STAR have developed a method to obtain a holistic view of the identities and proportions of immune cells in patient blood samples.
The AllerCatPro analysis workflow helps researchers predict the likelihood of a protein producing an allergic response in people.
Deciphering the immune response in mosquitoes to the O’nyong nyong virus may lead to new broad-spectrum antiviral targets.
Researchers have obtained a high-resolution structure of the RIP2 protein complex and detailed its interactions with other immune proteins.
A*STAR researchers have devised a method to generate a renewable source of mature human Kupffer cells for liver toxicity bioassays.
When parts of a bacteria’s cell wall enter into circulation, its host experiences more severe autoimmune reactions.
A subset of skin-resident immune cells secrete the protein VEGFα to help mount a robust response to bacterial invasion.